Pacific Hospital Supply Co., Ltd (TPEX:4126)
Taiwan · Delayed Price · Currency is TWD 86.90
-0.10 (-0.11%)
Dec 5, 2025, 1:30 PM CST
Pacific Hospital Supply Income Statement
Financials in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
| 2,469 | 2,345 | 2,320 | 2,185 | 2,019 | 2,172 | Upgrade | |
Revenue Growth (YoY) | 10.92% | 1.08% | 6.19% | 8.23% | -7.05% | 6.43% | Upgrade |
Cost of Revenue | 1,683 | 1,598 | 1,580 | 1,597 | 1,495 | 1,494 | Upgrade |
Gross Profit | 786.04 | 746.84 | 739.75 | 587.97 | 523.42 | 678.21 | Upgrade |
Selling, General & Admin | 192.37 | 184.05 | 184.31 | 187.36 | 162.72 | 192.12 | Upgrade |
Research & Development | 81.26 | 73.02 | 57.42 | 46.12 | 47.3 | 45.18 | Upgrade |
Operating Expenses | 273.63 | 257.07 | 241.73 | 233.48 | 210.02 | 237.3 | Upgrade |
Operating Income | 512.41 | 489.77 | 498.01 | 354.5 | 313.4 | 440.92 | Upgrade |
Interest Expense | -5.98 | -6.55 | -5.73 | -7.03 | -8.61 | -11.25 | Upgrade |
Interest & Investment Income | 20.58 | 22.35 | 17.61 | 3.72 | 0.25 | 0.69 | Upgrade |
Currency Exchange Gain (Loss) | -37.17 | 35.86 | -1.65 | 37.05 | -38.51 | -20.69 | Upgrade |
Other Non Operating Income (Expenses) | 12.03 | 16.67 | 20.01 | 19.96 | 17.56 | 16.09 | Upgrade |
EBT Excluding Unusual Items | 501.87 | 558.1 | 528.26 | 408.19 | 284.09 | 425.76 | Upgrade |
Gain (Loss) on Sale of Assets | 0.83 | -1.29 | -2.77 | 5.29 | 149.93 | -3.05 | Upgrade |
Pretax Income | 502.7 | 556.82 | 525.49 | 413.48 | 434.03 | 422.71 | Upgrade |
Income Tax Expense | 99.73 | 108.97 | 104.7 | 82.08 | 47.61 | 93.99 | Upgrade |
Net Income | 402.97 | 447.85 | 420.79 | 331.4 | 386.42 | 328.72 | Upgrade |
Net Income to Common | 402.97 | 447.85 | 420.79 | 331.4 | 386.42 | 328.72 | Upgrade |
Net Income Growth | -2.37% | 6.43% | 26.97% | -14.24% | 17.55% | -28.40% | Upgrade |
Shares Outstanding (Basic) | 73 | 73 | 73 | 73 | 73 | 73 | Upgrade |
Shares Outstanding (Diluted) | 73 | 73 | 73 | 73 | 73 | 73 | Upgrade |
Shares Change (YoY) | 0.03% | -0.05% | 0.05% | 0.06% | -0.00% | -0.02% | Upgrade |
EPS (Basic) | 5.55 | 6.17 | 5.80 | 4.56 | 5.32 | 4.53 | Upgrade |
EPS (Diluted) | 5.51 | 6.13 | 5.76 | 4.54 | 5.29 | 4.50 | Upgrade |
EPS Growth | -2.64% | 6.42% | 26.87% | -14.18% | 17.56% | -28.46% | Upgrade |
Free Cash Flow | 465.52 | 464.13 | 625.83 | 400.96 | 288.34 | 492.46 | Upgrade |
Free Cash Flow Per Share | 6.37 | 6.36 | 8.56 | 5.49 | 3.95 | 6.75 | Upgrade |
Dividend Per Share | 5.000 | 5.000 | 4.800 | 4.200 | 4.500 | 4.200 | Upgrade |
Dividend Growth | 4.17% | 4.17% | 14.29% | -6.67% | 7.14% | 15.47% | Upgrade |
Gross Margin | 31.84% | 31.85% | 31.88% | 26.91% | 25.93% | 31.23% | Upgrade |
Operating Margin | 20.76% | 20.88% | 21.46% | 16.23% | 15.52% | 20.30% | Upgrade |
Profit Margin | 16.32% | 19.10% | 18.14% | 15.17% | 19.14% | 15.14% | Upgrade |
Free Cash Flow Margin | 18.86% | 19.79% | 26.97% | 18.35% | 14.28% | 22.68% | Upgrade |
EBITDA | 632.29 | 612.87 | 624.99 | 487.38 | 458.58 | 594.59 | Upgrade |
EBITDA Margin | 25.61% | 26.13% | 26.94% | 22.31% | 22.72% | 27.38% | Upgrade |
D&A For EBITDA | 119.89 | 123.1 | 126.98 | 132.89 | 145.18 | 153.68 | Upgrade |
EBIT | 512.41 | 489.77 | 498.01 | 354.5 | 313.4 | 440.92 | Upgrade |
EBIT Margin | 20.76% | 20.88% | 21.46% | 16.23% | 15.52% | 20.30% | Upgrade |
Effective Tax Rate | 19.84% | 19.57% | 19.92% | 19.85% | 10.97% | 22.23% | Upgrade |
Revenue as Reported | - | - | - | - | 2,019 | 2,172 | Upgrade |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.